Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
JournalIJU Case Reports
DOIs
Publication statusAccepted/In press - 2021

All Science Journal Classification (ASJC) codes

  • Urology

Cite this